Sign Up Today and Learn More About Hello Heart Stock
Invest in or calculate the value of your shares in Hello Heart or other pre-IPO companies through EquityZen's platform.
Hello Heart Stock (HELH)
Hello Heart provides cardiovascular digital therapeutics to help people understand and improve their heart health using technology.
About Hello Heart Stock
Founded
2013
Industries
Health Care, Sports, Mobile
Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to use and helps participants improve their heart health in a fun and engaging way.
Hello Heart Press Mentions
Stay in the know about the latest news on Hello Heart
Sara Deshpande brings 'tough love' to seed investing — and why she's not backing down in a turbulent market
businessinsider • May 17, 2025
Hello Heart Unveils Connected Pill Box to Radically Improve Medication Adherence
businesswire • Apr 07, 2025
Amwell expands clinical programs portfolio to include Hello Heart
thefly • Oct 08, 2024
Marjorie Kramer on LinkedIn: The state of US women’s heart health: A path to improved health and…
linkedin • Aug 03, 2024
Hello Heart on LinkedIn: #menshealthmonth #menshealth #hearthealth #cvd
linkedin • Aug 03, 2024
Hello Heart Management
Leadership team at Hello Heart
CTO
Michal Gutman
CEO & Co-Founder
Maayan Cohen
Join now and verify your accreditation status to gain access to:
- Hello Heart Current Valuation
- Hello Heart Stock Price
- Hello Heart Management
- Available deals in Hello Heart and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Hello Heart Cap Table and Funding History by Share Class and Liquidity Preferences
- Hello Heart Revenue and Financials
- Hello Heart Highlights
- Hello Heart Business Model
- Hello Heart Risk Factors
- Hello Heart Research Report from SACRA Research
Trading Hello Heart Stock
How to invest in Hello Heart stock?
Accredited investors can buy pre-IPO stock in companies like Hello Heart through EquityZen funds. These investments are made available by existing Hello Heart shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Hello Heart stock?
Shareholders can sell their Hello Heart stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
